Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spinoza is an Israel-based biotechnology company focused on the development of psychedelic-based therapeutic solutions for neurological and psychiatric conditions. The company's primary research centers on utilizing psilocybin and other psychedelic compounds to treat cluster headaches, a debilitating condition with limited effective treatment options. Spinoza aims to bridge the gap between traditional psychedelic wellness and rigorous pharmaceutical drug development by conducting clinical-grade research. Their approach combines botanical expertise with modern pharmacology to create standardized, effective treatments for mental health and pain management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spinoza.